Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycosaminoglycans (GAGs), specifically heparin and heparan sulfate, are complex, highly sulfated linear polysaccharides found on cell surfaces and within the extracellular matrix. They play a critical role in biological processes by interacting with a vast array of proteins, including growth factors, antithrombin, cytokines, and viral attachment proteins. In healthy physiology, they regulate blood coagulation and cell signaling; however, in disease states, they are exploited by viruses for cellular entry and by cancer cells to facilitate angiogenesis and metastasis. Heparan sulfate serves as a co-receptor for various ligands, while heparin is a potent natural anticoagulant stored in mast cells. Therapeutic targeting of these molecules involves neutralizing their negative charge, using mimetics to block protein interactions, or inhibiting the enzymes like heparanase that modify them. Understanding the GAG interactome is essential for developing treatments for thrombosis, inflammatory disorders, and infectious diseases.
Drugs targeting these molecules typically act through electrostatic neutralization (e.g., protamine binding to acidic heparin), competitive inhibition of ligand-GAG interactions (e.g., HS mimetics blocking growth factor binding), or enzymatic degradation of the polysaccharide chains to disrupt the extracellular matrix and signaling scaffolds.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycosaminoglycan (Heparin and Heparan sulfate) (GAG).